PON1 and diabetes mellitus: Due to its influence on oxidative stress and inflammation, the activity of the HDL-associated enzyme paraoxonase 1 (PON1) has been investigated in several pathological conditions, including vascular diseases (32, 33), renal disease (34, 35), diabetes (36–39), and cancer (40).